Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Kvarnhammar AM"'
Autor:
Rosen DB; Ascendis Pharma Inc, Redwood City, California, USA drn@ascendispharma.com., Kvarnhammar AM; Ascendis Pharma A/S, Hellerup, Denmark., Laufer B; Ascendis Pharma GmbH, Heidelberg, Germany., Knappe T; Ascendis Pharma GmbH, Heidelberg, Germany., Karlsson JJ; Ascendis Pharma A/S, Hellerup, Denmark., Hong E; Ascendis Pharma Inc, Redwood City, California, USA., Lee YC; Ascendis Pharma Inc, Redwood City, California, USA., Thakar D; Ascendis Pharma Inc, Redwood City, California, USA., Zúñiga LA; Ascendis Pharma Inc, Redwood City, California, USA., Bang K; Ascendis Pharma Inc, Redwood City, California, USA., Sabharwal SS; Ascendis Pharma Inc, Redwood City, California, USA., Uppal K; Ascendis Pharma Inc, Redwood City, California, USA., Olling JD; Ascendis Pharma A/S, Hellerup, Denmark., Kjaergaard K; Ascendis Pharma A/S, Hellerup, Denmark., Kurpiers T; Ascendis Pharma GmbH, Heidelberg, Germany., Schnabel M; Ascendis Pharma GmbH, Heidelberg, Germany., Reich D; Ascendis Pharma GmbH, Heidelberg, Germany., Glock P; Ascendis Pharma GmbH, Heidelberg, Germany., Zettler J; Ascendis Pharma GmbH, Heidelberg, Germany., Krusch M; Ascendis Pharma GmbH, Heidelberg, Germany., Bernhard A; Ascendis Pharma GmbH, Heidelberg, Germany., Heinig S; Ascendis Pharma GmbH, Heidelberg, Germany., Konjik V; Ascendis Pharma GmbH, Heidelberg, Germany., Wegge T; Ascendis Pharma GmbH, Heidelberg, Germany., Hehn Y; Ascendis Pharma GmbH, Heidelberg, Germany., Killian S; Ascendis Pharma GmbH, Heidelberg, Germany., Viet L; Ascendis Pharma GmbH, Heidelberg, Germany., Runz J; Ascendis Pharma GmbH, Heidelberg, Germany., Faltinger F; Ascendis Pharma GmbH, Heidelberg, Germany., Tabrizi M; Ascendis Pharma Inc, Redwood City, California, USA., Abel KL; Ascendis Pharma A/S, Hellerup, Denmark., Breinholt VM; Ascendis Pharma A/S, Hellerup, Denmark., Singel SM; Ascendis Pharma Inc, Palo Alto, California, USA., Sprogøe K; Ascendis Pharma A/S, Hellerup, Denmark., Punnonen J; Ascendis Pharma Inc, Redwood City, California, USA.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Jul; Vol. 10 (7).
Autor:
Kvarnhammar AM; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden. amk@alligatorbioscience.com., Veitonmäki N; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Hägerbrand K; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Dahlman A; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Smith KE; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Fritzell S; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., von Schantz L; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Thagesson M; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Werchau D; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Smedenfors K; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Johansson M; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Rosén A; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Åberg I; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Winnerstam M; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Nyblom E; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Barchan K; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Furebring C; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Norlén P; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden., Ellmark P; Alligator Bioscience AB, Medicon Village, Scheelevägen 2, 223 81, Lund, Sweden.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2019 Apr 11; Vol. 7 (1), pp. 103. Date of Electronic Publication: 2019 Apr 11.
Autor:
Schultz HS; Immunogenicity Prediction and Tolerance, Global Research, Novo Nordisk A/S, Måløv, Denmark., Reedtz-Runge SL; NCD Project Management, Global Research, Novo Nordisk A/S, Måløv, Denmark., Bäckström BT; Immunogenicity Prediction and Tolerance, Global Research, Novo Nordisk A/S, Måløv, Denmark., Lamberth K; Immunogenicity Prediction and Tolerance, Global Research, Novo Nordisk A/S, Måløv, Denmark., Pedersen CR; Immunogenicity Assessment, Global Research, Novo Nordisk A/S, Måløv, Denmark., Kvarnhammar AM; Immunogenicity Prediction and Tolerance, Global Research, Novo Nordisk A/S, Måløv, Denmark.
Publikováno v:
PloS one [PLoS One] 2017 May 31; Vol. 12 (5), pp. e0178544. Date of Electronic Publication: 2017 May 31 (Print Publication: 2017).
Autor:
Bogefors J; Laboratory of Clinical and Experimental Allergy Research, Department of Otorhinolaryngology, Skånes University Hospital, Lund University, Malmö, Sweden., Kvarnhammar AM, Millrud CR, Georén SK, Cardell LO
Publikováno v:
Pathogens and disease [Pathog Dis] 2014 Oct; Vol. 72 (1), pp. 55-60. Date of Electronic Publication: 2014 Jun 12.
Autor:
Tengroth L; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Millrud CR; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Kvarnhammar AM; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Kumlien Georén S; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden., Latif L; Department of Otorhinolaryngology, Skåne University Hospital, Lund University, Malmö, Sweden., Cardell LO; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Publikováno v:
PloS one [PLoS One] 2014 Jun 02; Vol. 9 (6), pp. e98239. Date of Electronic Publication: 2014 Jun 02 (Print Publication: 2014).
Autor:
Millrud CR; Division of ENT Diseases, Department of Clinical Science, Intervention and Technology, Karolinska Institutet , Stockholm , Sweden., Kvarnhammar AM, Tajti J, Munck-Wikland E, Uddman R, Cardell LO
Publikováno v:
Acta oto-laryngologica [Acta Otolaryngol] 2013 Dec; Vol. 133 (12), pp. 1333-44. Date of Electronic Publication: 2013 Sep 23.
Autor:
Bogefors J; Laboratory of Clinical and Experimental Allergy Research, Department of Otorhinolaryngology, Skåne University Hospital, Lund University, Malmö, Sweden., Kvarnhammar AM, Cardell LO
Publikováno v:
International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2013 Feb; Vol. 3 (2), pp. 99-103. Date of Electronic Publication: 2012 Dec 16.
Autor:
Bogefors J; Laboratory of Clinical and Experimental Allergy Research, Department of Otorhinolaryngology, Skåne University Hospital, Lund University, Malmö, Sweden., Kvarnhammar AM, Höckerfelt U, Cardell LO
Publikováno v:
FEMS immunology and medical microbiology [FEMS Immunol Med Microbiol] 2012 Aug; Vol. 65 (3), pp. 431-8. Date of Electronic Publication: 2012 May 04.
Autor:
Kvarnhammar AM; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden. anne.mansson.kvarnhammar@ki.se, Cardell LO
Publikováno v:
Immunology [Immunology] 2012 May; Vol. 136 (1), pp. 11-20.
Autor:
Kvarnhammar AM; Division of ENT Diseases, Department of Clinical Sciences, Intervention and Technology, Karolinska Institutet, Huddinge, Sweden. anne.mansson.kvarnhammar@ki.se, Rydberg C, Järnkrants M, Eriksson M, Uddman R, Benson M, Cardell LO
Publikováno v:
Respiratory research [Respir Res] 2012 Jan 09; Vol. 13, pp. 2. Date of Electronic Publication: 2012 Jan 09.